Anti-CD19/CD22 Bispecific CAR-T Cell Therapy for CD19-positive ALL

Conditions

• CD19-positive ALL

Interventions

• BIOLOGICAL: anti-CD19/CD22 CAR-T cells
• DRUG: Fludarabine
• DRUG: Cyclophosphamide

Sponsor

The Second Affiliated Hospital of Henan University of Traditional Chinese Medicine

Collaborators

• [object Object]
• [object Object]
• [object Object]